Nomad Foods (NYSE:NOMD – Get Free Report) and Medifast (NYSE:MED – Get Free Report) are both consumer staples companies, but which is the better investment? Get Nomad Foods alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nomad Foods $3.35 billion 0.60 $245.74 million $1.46 9.06 Medifast $480.45 million 0.31 $2.09 million $0.32 42.70DividendsNomad Foods has higher revenue and earnings than Medifast. Nomad Foods is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. Given Nomad Foods’ stronger consensus rating and higher possible upside, equities analysts clearly believe Nomad Foods is more favorable than Medifast. Receive News & Ratings for Nomad Foods Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nomad Foods and related companies with MarketBeat.com's FREE daily email newsletter.